glp 1 drugs and multiple sclerosis Can GLP-1 Help People with MS? You might know them as

Objective To assess whether use of glucagon-like peptide-1 (GLP-1) receptor agonists before upper gastrointestinal endoscopy is associated with increased risk of pulmonary aspiration or discontinuation of the procedure compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors

Phentermine and GLP-1 receptor agonists are distinct medications that work through different biological pathways to support weight loss

Considering GLP-1s or Phentermine for weight loss

Limitations The major limitations of the studies that are included in this systematic review are the enrollment of healthy subjects and insufficient data in conditions that might affect pharmacokinetics (e.g., kidney dysfunction)

Glucagon-like peptide-1 (GLP-1) is a hormone involved in glucose homeostasis and satiety regulation

Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases